Literature DB >> 22372781

Aliskiren: a potential antiarrhythmic drug?

Vivencio Barrios, Carlos Escobar, Alberto Calderon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22372781      PMCID： PMC8108952          DOI： 10.1111/j.1751-7176.2011.00589.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  5 in total

1.  Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus.

Authors:  R Fogari; A Zoppi; P Maffioli; C Monti; P Lazzari; A Mugellini; G Derosa
Journal:  Diabetes Obes Metab       Date:  2011-12-27       Impact factor: 6.577

2.  Patients with atrial fibrillation in a primary care setting: Val-FAAP study.

Authors:  Vivencio Barrios; Alberto Calderón; Carlos Escobar; Mariano de la Figuera
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2011-11-04

3.  Electromechanical effects of the direct renin inhibitor (aliskiren) on the pulmonary vein and atrium.

Authors:  Chin-Feng Tsai; Yao-Chang Chen; Yung-Kuo Lin; Shih-Ann Chen; Yi-Jen Chen
Journal:  Basic Res Cardiol       Date:  2011-07-21       Impact factor: 17.165

4.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

Authors:  Giuseppe Mancia; Stéphane Laurent; Enrico Agabiti-Rosei; Ettore Ambrosioni; Michel Burnier; Mark J Caulfield; Renata Cifkova; Denis Clément; Antonio Coca; Anna Dominiczak; Serap Erdine; Robert Fagard; Csaba Farsang; Guido Grassi; Hermann Haller; Anthony Heagerty; Sverre E Kjeldsen; Wolfgang Kiowski; Jean Michel Mallion; Athanasios Manolis; Krzysztof Narkiewicz; Peter Nilsson; Michael H Olsen; Karl Heinz Rahn; Josep Redon; José Rodicio; Luis Ruilope; Roland E Schmieder; Harry A J Struijker-Boudier; Pieter A van Zwieten; Margus Viigimaa; Alberto Zanchetti
Journal:  J Hypertens       Date:  2009-11       Impact factor: 4.844

Review 5.  Renin inhibitors.

Authors:  Naomi D L Fisher; Emma A Meagher
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-27       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.